Tavexia Lifecare Ltd (NSE: TAVEXIA), ISIN INE280E01038 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
TAVEXIA last traded at ₹1.05 (+19.32%), with a 52-week range of ₹0.49 to ₹1.05 (as of 26 Aug 2026).
Shareholding as of Dec 2025: promoters 6.40%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 32/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.